e8vk
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 26, 2003

OrthoLogic Corp.


(Exact name of registrant as specified in its charter)

Delaware


(State or other jurisdiction of incorporation)
     
0-21214   86-0585310

 
(Commission File Number)   (IRS Employer Identification Number)
     
1275 West Washington, Phoenix, Arizona   85281

 
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (602) 286-5520

Not Applicable


(Former name or former address, if changed since last report)

 


TABLE OF CONTENTS

Item 2. Acquisition or Disposition of Assets
Item 7. Financial Statements and Exhibits
UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEETS
Notes to Unaudited Pro forma Consolidated Balance Sheets:
UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS
Notes to Unaudited Pro forma Consolidated Statements of Operations
SIGNATURES
EXHIBIT INDEX
EX-2.1
EX-2.2


Table of Contents

Item 2. Acquisition or Disposition of Assets

     On November 26, 2003, OrthoLogic Corp. completed its previously announced sale of substantially all its bone device business assets pursuant to an Asset Purchase Agreement dated October 8, 2003, as amended on November 26, 2003 (the “Asset Purchase Agreement”). At the closing, OrthoLogic Corp. received $93.0 million from dj Orthopedics, LLC, a wholly-owned subsidiary of dj Orthopedics, Inc., as the purchase price of the bone device business assets (the “Bone Device Business”), of which $7.5 million was put into escrow accounts and from which certain escrow fees were paid. dj Orthopedics, LLC also assumed approximately $1.4 million of OrthoLogic Corp.’s liabilities.

     Of the $7.5 million deposited into escrow accounts, $7.0 million was placed into an account that dj Orthopedics, LLC may draw upon to fund any claims against OrthoLogic Corp. deemed eligible for indemnification. The remaining $0.5 million was placed into an escrow account to fund the payment of employee stay-bonuses described in the Asset Purchase Agreement. Any remaining funds held in escrow in excess of the aggregate amount of any pending claims, together with any earnings or interest, will be released to OrthoLogic Corp. on the second anniversary of the closing.

     The purchase price was determined in an arm’s length negotiation. Neither dj Orthopedics, LLC nor dj Orthopedics, Inc. was affiliated with OrthoLogic Corp., its directors, officers or any associates of any OrthoLogic Corp. director or officer.

     A copy of the press release announcing the transaction was filed as exhibit 99.1 to OrthoLogic Corp.’s Form 8-K filed November 26, 2003. A copy of the executed Asset Purchase Agreement and the Amendment No. 1 to the Asset Purchase Agreement are filed with this Form 8-K and are incorporated herein by reference. The foregoing description of the transaction is qualified in its entirety by the complete text of the Asset Purchase Agreement and Amendment No. 1 to the Asset Purchase Agreement attached hereto.

Item 7. Financial Statements and Exhibits

(a)   Financial statements of the business acquired. None.

(b)   Pro forma financial information.

    See below.

 


Table of Contents

UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS

     The following unaudited pro forma condensed consolidated financial statements are based on the historical consolidated financial statements of OrthoLogic Corp. and subsidiaries, adjusted to give effect to the disposition of the bone device business assets (the “Bone Device Business”) in accordance with the Asset Purchase Agreement dated October 8, 2003 between us and dj Orthopedics, LLC.

     The unaudited pro forma consolidated balance sheets give effect to the proposed transaction as if it occurred on the date of the balance sheet. The cash proceeds and resulting gain are only included in the September 30, 2003 balance sheet. The unaudited pro forma consolidated statements of operations for the nine months ended September 30, 2003 and 2002 and the years ended December 31, 2002, 2001 and 2000 give effect to the transaction as if it had occurred as of January 1, 2000.

     The pro forma consolidated financial information is presented for illustrative purposes only, and is not necessarily indicative of the operating results or financial position that would have occurred if all of the events as described above had occurred on the first day of the respective periods presented, nor is it necessarily indicative of our future operating results or financial position. The unaudited pro forma condensed consolidated financial statements should be read in conjunction with OrthoLogic’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002.

 


Table of Contents

ORTHOLOGIC CORP.
UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET
(in thousands, except per share data)
September 30, 2003

                             
        Historical   Sale of Bone   Proforma
        OrthoLogic   Device Business   OrthoLogic
       
 
 
ASSETS
                       
Current Assets:
                       
 
Cash and cash equivalents
  $ 12,287     $ 80,500 (2)   $ 92,787  
 
Short-term Investments
    22,174             22,174  
 
Accounts receivable less allowance for doubtful accounts
    9,479       (8,398 )(1)     1,081  
 
Inventories, net
    2,284       (2,284 )(1)      
 
Prepaids and other current assets
    595       (47 )(1)     548  
 
Deferred income taxes – current
    1,667       (1,667 )(1)      
 
   
     
     
 
 
Total current assets
    48,486       68,104       116,590  
 
Furniture and equipment, net
    1,245       (690 )(1)     555  
Long-term investments
    5,024             5,024  
Deferred income taxes — non-current
    964       (964 )(1)      
Deposits and other assets
    210       (9 )(1)     201  
Escrow deposit receivable
          7,500 (2)     7,500  
Investment in Chrysalis BioTechnology
    750             750  
 
   
     
     
 
 
Total assets
  $ 56,679     $ 73,941     $ 130,620  
 
   
     
     
 
LIABILITIES & STOCKHOLDERS’ EQUITY
                       
Current Liabilities:
                       
 
Accounts payable
  $ 988     $ (613 )(1)   $ 375  
 
Income taxes payable
          5,000 (2)     5,000  
 
Accrued compensation
    2,295       (544 )(1)     1,751  
 
Accrued CPM divestiture costs
                 
 
Other accrued liabilities
    2,982       (671 )(1)     2,311  
 
          500 (2)     500  
 
 
   
     
     
 
 
Total current liabilities
    6,265       3,672       9,937  
Deferred rent and capital lease obligation
    298             298  
 
   
     
     
 
 
Total liabilities
    6,563       3,672       10,235  
 
   
     
     
 
Commitments and contingencies
                       
STOCKHOLDERS’ EQUITY
                       
 
Common stock, $.0005 par value:
                       
   
50,000,000 shares authorized; and 32,933,096 and 32,891,296 shares issued and outstanding
    16             16  
 
Additional paid-in capital
    139,700             139,700  
 
Accumulated deficit
    (89,463 )     70,269 (2)     (19,194 )
 
Treasury stock at cost, 41,800 shares
    (137 )           (137 )
 
 
   
     
     
 
 
Total stockholders’ equity
    50,116       70,269       120,385  
 
   
     
     
 
 
Total liabilities and stockholders’ equity
  $ 56,679     $ 73,941     $ 130,620  
 
   
     
     
 

See notes to unaudited pro forma consolidated balance sheets.

 


Table of Contents

ORTHOLOGIC CORP.
UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET
(in thousands, except per share data)
December 31, 2002

                             
        Historical   Sale of Bone   Proforma
        OrthoLogic   Device Business   OrthoLogic
       
 
 
ASSETS
                       
Current Assets:
                       
 
Cash and cash equivalents
  $ 11,286           $ 11,286  
 
Short-term Investments
    18,660             18,660  
 
Accounts receivable less allowance for doubtful accounts
    9,641       (8,313 )(1)     1,328  
 
Inventories, net
    2,568       (2,568 )(1)      
 
Prepaids and other current assets
    598       (61 )(1)     537  
 
Deferred income taxes — current
    1,667       (1,667 )(1)      
 
   
     
     
 
 
Total current assets
    44,420       (12,609 )     31,811  
 
Furniture and equipment, net
    1,498       (711 )(1)     787  
Long-term investments
    5,659             5,659  
Deferred income taxes — non-current
    964       (964 )(1)      
Deposits and other assets
    129       (11 )(1)     118  
Investment in Chrysalis BioTechnology
    750             750  
 
   
     
     
 
 
Total assets
  $ 53,420     $ (14,295 )   $ 39,125  
 
   
     
     
 
LIABILITIES & STOCKHOLDERS’ EQUITY
                       
Current Liabilities:
                     
 
Accounts payable
  $ 478     $ (312 )(1)   $ 166  
 
Accrued compensation
    2,290       (58 )(1)     2,232  
 
Accrued CPM divestiture costs
    210             210  
 
Other accrued liabilities
    1,857       (560 )(1)     1,297  
 
   
     
     
 
 
Total current liabilities
    4,835       (930 )     3,905  
Deferred rent and capital lease obligation
    352             352  
 
   
     
     
 
 
Total liabilities
    5,187       (930 )     4,257  
 
   
     
     
 
Commitments and contingencies
                       
STOCKHOLDERS’ EQUITY
                       
 
Common stock, $.0005 par value:
                       
   
50,000,000 shares authorized; and 32,088,021 and 32,047,021 shares issued and outstanding
    16             16  
 
Additional paid-in capital
    136,945             136,945  
 
Common stock to be issued for legal settlement
    2,078             2,078  
 
Accumulated deficit
    (90,669 )     (13,365 )(1)     (104,034 )
 
Treasury stock at cost, 41,800 shares
    (137 )           (137 )
 
   
     
     
 
 
Total stockholders’ equity
    48,233       (13,365 )     34,868  
 
   
     
     
 
 
Total liabilities and stockholders’ equity
  $ 53,420     $ (14,295 )   $ 39,125  
 
   
     
     
 

See notes to unaudited pro forma consolidated balance sheets.

 


Table of Contents

ORTHOLOGIC CORP.
UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET
(in thousands, except per share data)
December 31, 2001

                           
      Historical   Sale of Bone   Proforma
      OrthoLogic   Device Business   OrthoLogic
     
 
 
ASSETS
                       
Current Assets:
                       
 
Cash and cash equivalents
  $ 19,503           $ 19,503  
 
Short-term Investments
    11,008             11,008  
 
Accounts receivable less allowance for doubtful accounts
    11,362       (8,578 )(1)     2,784  
 
Inventories, net
    1,507       (1,507 )(1)      
 
Prepaids and other current assets
    687       (101 )(1)     586  
 
Deferred income taxes — current
    2,631       (2,631 )(1)      
 
   
     
     
 
 
Total current assets
    46,698       (12,817 )     33,881  
 
Furniture and equipment, net
    1,902       (903 )(1)     999  
Long-term investments
                 
Deferred income taxes — non-current
                 
Deposits and other assets
    92       (7 )(1)     85  
Investment in Chrysalis BioTechnology
    750             750  
 
   
     
     
 
 
Total assets
  $ 49,442     $ (13,727 )   $ 35,715  
 
   
     
     
 
LIABILITIES & STOCKHOLDERS’ EQUITY
                       
Current Liabilities:
                       
 
Accounts payable
  $ 776     $ (458 )(1)   $ 318  
 
Accrued compensation
    2,415       (164 )(1)     2,251  
 
Accrued CPM divestiture costs
    2,446             2,446  
 
Other accrued liabilities
    1,022       (848 )(1)     174  
 
   
     
     
 
 
Total current liabilities
    6,659       (1,470 )     5,189  
Deferred rent and capital lease obligation
    287             287  
 
   
     
     
 
 
Total liabilities
    6,946       (1,470 )     5,476  
 
   
     
     
 
Commitments and contingencies
 
Series B Convertible Preferred Stock, $1,000 per value; 600 shares issued and outstanding; liquidation preference, $600,000 at December 31, 2001
    600               600  
 
   
             
 
STOCKHOLDERS’ EQUITY
                       
 
Common stock, $.0005 par value:
                       
 
50,000,000 shares authorized; and 32,088,021 and 32,047,021 shares issued and outstanding
    16             16  
 
Additional paid-in capital
    136,216             136,216  
 
Common stock to be issued for legal settlement
    2,078             2,078  
 
Accumulated deficit
    (96,277 )     (12,257 )(1)     (108,534 )
 
Treasury stock at cost, 41,800 shares
    (137 )           (137 )
 
   
     
     
 
 
Total stockholders’ equity
    41,896       (12,257 )     29,639  
 
   
     
     
 
 
Total liabilities and stockholders’ equity
  $ 49,442     $ (13,727 )   $ 35,715  
 
   
     
     
 

See notes to unaudited pro forma consolidated balance sheets.

 


Table of Contents

Notes to Unaudited Pro forma Consolidated Balance Sheets:

Divestiture

On November 26, 2003, OrthoLogic Corp. completed its previously announced sale of substantially all its bone device business assets pursuant to an Asset Purchase Agreement dated October 8, 2003, as amended on November 26, 2003. At the closing, OrthoLogic Corp. received $93.0 million from dj Orthopedics, LLC, a wholly-owned subsidiary of dj Orthopedics, Inc., as the purchase price of the bone device business assets, of which $7.5 million was put into escrow accounts and from which certain escrow fees were paid. dj Orthopedics, LLC also assumed approximately $1.4 million of Orthologic Corp.’s liabilities.

Of the $7.5 million deposited into escrow accounts, $7.0 million was placed into an account that dj Orthopedics, LLC may draw upon to fund any claims against OrthoLogic Corp. deemed eligible for indemnification. The remaining $0.5 million was placed into an escrow account to fund the payment of employee stay-bonuses described in the Asset Purchase Agreement. Any remaining funds held in escrow in excess of the aggregate amount of any pending claims, together with any earnings or interest, will be released to OrthoLogic Corp. on the second anniversary of the closing.

  (1)   To give effect to the disposition of the Bone Device Business as of balance sheet date presented. Pursuant to the Asset Purchase Agreement, Orthologic Corp. sold substantially all of the assets of the Bone Device Business, including substantially all of the related machinery, equipment, inventory, work in process, licenses, customer lists and intellectual property and certain agreements and contracts to dj Orthopedics. dj Orthopedics assumed substantially all of the Bone Device Business trade payables and other current liabilities less payables in an amount approximately equal to the amount of retained Medicare receivables. Therefore, the adjustment removes the related historical assets and liabilities of the Bone Device Business that will not be retained by OrthoLogic Corp.

  (2)   To give effect to the net cash proceeds, gain on disposition and related income taxes as a result of the sale of the Bone Device Business as if it occurred on September 30, 2003. The cash amount reflects the $93.0 million payment from djOrthopedics net of the $7.5 million placed in escrow, shown as escrow deposit receivable, and direct costs of the transaction of $5.0 million, for net proceeds of $80.5 million. The gain reflected in accumulated deficit is composed primarily of the cash proceeds, net of the net assets sold, direct costs, and related income taxes payable and the increase of the valuation allowance for the remaining deferred tax asset.

 


Table of Contents

ORTHOLOGIC CORP.
UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS
(in thousands, except share and per share data)
Nine months ended September 30, 2003

                           
              Sale of    
      Historical   Bone Device   Proforma
      OrthoLogic   Business (1)   OrthoLogic
     
 
 
NET SALES
  $ 34,263     $ (34,263 )   $  
COST OF REVENUES
    5,088       (5,088 )      
 
   
     
     
 
GROSS PROFIT
    29,175       (29,175 )      
 
   
     
     
 
OPERATING EXPENSES
                       
 
Selling, general and administrative
    22,503       (18,820 )     3,683  
 
Research and development
    6,299       (236 )     6,063  
 
CPM divestiture and related charges
    (477 )           (477 )
 
   
     
     
 
 
Total operating expenses
    28,325       (19,056 )     9,269  
 
   
     
     
 
OPERATING INCOME (LOSS)
    850       (10,119 )     (9,269 )
OTHER INCOME
    387             387  
 
   
     
     
 
INCOME (LOSS) BEFORE INCOME TAXES
    1,237       (10,119 )     (8,882 )
 
Provision for income taxes
    31             31  
 
   
     
     
 
INCOME (LOSS) FROM CONTINUING OPERATIONS
  $ 1,206     $ (10,119 )   $ (8,913 )
 
   
     
     
 
 
Net income (loss) per common share — basic
  $ 0.04             $ (0.27 )
 
   
             
 
 
Net income (loss) per common share — diluted
  $ 0.04             $ (0.27 )
 
   
             
 
 
Basic shares outstanding
    32,892               32,892  
 
Equivalent shares
    385                
 
   
             
 
 
Diluted shares outstanding
    33,277               32,892  
 
   
             
 

See notes to unaudited pro forma consolidated statements of operations.

 


Table of Contents

ORTHOLOGIC CORP.
UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS
(in thousands, except per share data)
Nine months ended September 30, 2002

                           
              Sale of    
      Historical   Bone Device   Pro forma
      OrthoLogic   Business (1)   OrthoLogic
     
 
 
REVENUES
                       
 
Net sales
  $ 28,221     $ (28,221 )   $  
 
Royalties from co-promotion agreement
    1,872               1,872  
 
   
     
     
 
 
Total revenues
    30,093       (28,221 )     1,872  
COST OF REVENUES
    4,621       (4,621 )      
 
   
     
     
 
GROSS PROFIT
    25,472       (23,600 )     1,872  
 
   
     
     
 
OPERATING EXPENSES
                       
 
Selling, general and administrative
    20,534       (16,917 )     3,617  
 
Research and development
    2,391       (208 )     2,183  
 
CPM divestiture and related charges
    (1,047 )           (1,047 )
 
   
     
     
 
 
Total operating expenses
    21,878       (17,125 )     4,753  
 
   
     
     
 
OPERATING INCOME (LOSS)
    3,594       (6,475 )     (2,881 )
OTHER INCOME
    537             537  
 
   
     
     
 
INCOME (LOSS) BEFORE INCOME TAXES
    4,131       (6,475 )     (2,344 )
 
Provision for income taxes
    37             37  
 
   
     
     
 
INCOME (LOSS) FROM CONTINUING OPERATIONS
  $ 4,094     $ (6,475 )   $ (2,381 )
 
   
     
     
 
 
Net income (loss) per common share — basic
  $ 0.13             $ (0.07 )
 
   
             
 
 
Net income (loss) per common share — diluted
  $ 0.13             $ (0.07 )
 
   
             
 
 
Basic shares outstanding
    32,615               32,615  
 
Equivalent shares
    96                
 
   
             
 
 
Diluted shares outstanding
    32,711               32,615  
 
   
             
 

See notes to unaudited pro forma consolidated statements of operations.

 


Table of Contents

ORTHOLOGIC CORP.
UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS
(in thousands, except share and per share data)
Year ended December 31, 2002

                           
              Sale of    
      Historical   Bone Device   Pro forma
      OrthoLogic   Business (1)   OrthoLogic
     
 
 
REVENUES
                       
 
Net sales
  $ 38,159     $ (38,159 )   $  
 
Royalties from co-promotion agreement
    2,230             2,230  
 
   
     
     
 
 
Total revenues
    40,389       (38,159 )     2,230  
COST OF REVENUES
    6,158       (6,158 )      
 
   
     
     
 
GROSS PROFIT
    34,231       (32,001 )     2,230  
 
   
     
     
 
OPERATING EXPENSES
                       
 
Selling, general and administrative
    26,604       (22,028 )     4,576  
 
Research and development
    3,765       (277 )     3,488  
 
CPM divestiture and related charges
    (1,047 )           (1,047 )
 
   
     
     
 
 
Total operating expenses
    29,322       (22,305 )     7,017  
 
   
     
     
 
OPERATING INCOME (LOSS)
    4,909       (9,696 )     (4,787 )
OTHER INCOME
    706             706  
 
   
     
     
 
INCOME (LOSS) BEFORE INCOME TAXES
    5,615       (9,696 )     (4,081 )
 
Provision for income taxes
    6             6  
 
   
     
     
 
INCOME (LOSS) FROM CONTINUING OPERATIONS
  $ 5,609     $ (9,696 )   $ (4,087 )
 
   
     
     
 
 
Net income (loss) per common share — basic
  $ 0.17             $ (0.13 )
 
   
             
 
 
Net income (loss) per common share — diluted
  $ 0.17             $ (0.13 )
 
   
             
 
 
Basic shares outstanding
    32,556               32,556  
 
Equivalent shares
    808                
 
   
             
 
 
Diluted shares outstanding
    33,364               32,556  
 
   
             
 

See notes to unaudited pro forma consolidated statements of operations.

 


Table of Contents

ORTHOLOGIC CORP.
UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS
(in thousands, except share and per share data)
Year ended December 31, 2001

                           
              Sale of    
      Historical   Bone Device   Pro forma
      OrthoLogic   Business (1)   OrthoLogic
     
 
 
REVENUES
                       
 
Net sales
  $ 59,338     $ (30,477 )   $ 28,861  
 
Royalties from co-promotion agreement
    3,018             3,018  
 
   
     
     
 
 
Total revenues
    62,356       (30,477 )     31,879  
COST OF REVENUES
    11,349       (5,538 )     5,811  
 
   
     
     
 
GROSS PROFIT
    51,007       (24,939 )     26,068  
 
   
     
     
 
OPERATING EXPENSES
                       
 
Selling, general and administrative
    46,556       (17,282 )     29,274  
 
Research and development
    3,889       (429 )     3,460  
 
CPM divestiture and related charges
    14,327             14,327  
 
   
     
     
 
 
Total operating expenses
    64,772       (17,711 )     47,061  
 
   
     
     
 
OPERATING INCOME (LOSS)
    (13,765 )     (7,228 )     (20,993 )
OTHER INCOME
    682             682  
 
   
     
     
 
INCOME (LOSS) BEFORE INCOME TAXES
    (13,083 )     (7,228 )     (20,311 )
 
Provision for income taxes
    12             12  
 
   
     
     
 
INCOME (LOSS) FROM CONTINUING OPERATIONS
  $ (13,095 )   $ (7,228 )   $ (20,323 )
 
   
     
     
 
 
Net income (loss) per common share — basic
  $ (0.42 )           $ (0.65 )
 
   
             
 
 
Net income (loss) per common share — diluted
  $ (0.42 )           $ (0.65 )
 
   
             
 
 
Basic and diluted shares outstanding
    31,293               31,293  
 
   
             
 

See notes to unaudited pro forma consolidated statements of operations.

 


Table of Contents

ORTHOLOGIC CORP.
UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS
(in thousands, except share and per share data)
Year ended December 31, 2000

                           
              Sale of    
      Historical   Bone Device   Pro forma
      OrthoLogic   Business (1)   OrthoLogic
     
 
 
REVENUES
                       
 
Net sales
  $ 80,769     $ (20,509 )   $ 60,260  
 
Royalties from co-promotion agreement
    9,310             9,310  
 
   
     
     
 
 
Total revenues
    90,079       (20,509 )     69,570  
COST OF REVENUES
    18,289       (4,186 )     14,103  
 
   
     
     
 
 
GROSS PROFIT
    71,790       (16,323 )     55,467  
 
   
     
     
 
OPERATING EXPENSES
                       
 
Selling, general and administrative
    71,727       (15,855 )     55,872  
 
Research and development
    4,689       (577 )     4,112  
 
Legal settlements
    4,499             4,499  
 
Write-off of goodwill
    23,348             23,348  
 
Net gain from discontinuation of co-promotion agreement
    (844 )           (844 )
 
   
     
     
 
 
Total operating expenses
    103,419       (16,432 )     86,987  
 
   
     
     
 
OPERATING INCOME (LOSS)
    (31,629 )     109       (31,520 )
OTHER INCOME
    451             451  
 
   
     
     
 
 
INCOME (LOSS) BEFORE INCOME TAXES
    (31,178 )     109       (31,069 )
 
Provision for income taxes
    12             12  
 
   
     
     
 
 
NET INCOME (LOSS)
  $ (31,190 )   $ 109     $ (31,081 )
 
   
     
     
 
 
Net income (loss) per common share — basic
  $ (1.04 )           $ (1.04 )
 
   
             
 
 
Net income (loss) per common share — diluted
  $ (1.04 )           $ (1.04 )
 
   
             
 
 
Basic and diluted shares outstanding
    29,855               29,855  
 
   
             
 

See notes to unaudited pro forma consolidated statements of operations.

 


Table of Contents

Notes to Unaudited Pro forma Consolidated Statements of Operations

Divestiture

On November 26, 2003, OrthoLogic Corp. completed its previously announced sale of substantially all its bone device business assets pursuant to an Asset Purchase Agreement dated October 8, 2003, as amended on November 26, 2003. At the closing, OrthoLogic Corp. received $93.0 million from dj Orthopedics, LLC, a wholly-owned subsidiary of dj Orthopedics, Inc., as the purchase price of the bone device business assets, of which $7.5 million was put into escrow accounts and from which certain escrow fees were paid. dj Orthopedics, LLC also assumed approximately $1.4 million of OrthoLogic Corp.’s liabilities.

Of the $7.5 million deposited into escrow accounts, $7.0 million was placed into an account that dj Orthopedics, LLC may draw upon to fund any claims against OrthoLogic Corp. deemed eligible for indemnification. The remaining $0.5 million was placed into an escrow account to fund the payment of employee stay-bonuses described in the Asset Purchase Agreement. Any remaining funds held in escrow in excess of the aggregate amount of any pending claims, together with any earnings or interest, will be released to OrthoLogic Corp. on the second anniversary of the closing.

  (1)   To reflect the elimination of the historical revenues as well as historical costs and expenses relating to the operations of the Bone Device Business pursuant to the Asset Purchase Agreement, as if the transactions were consummated as of January 1, 2000. Any gain related to this transaction is not reflected in the pro forma statements of operations. The historical expenses of the Bone Device Business were derived using a variety of factors including percentage of revenues, headcount and specific identification which management believes are reasonable and representative of such historical expenses.

(c) Exhibits

  2.1   Asset Purchase Agreement between OrthoLogic Corp. and dj Orthopedics, LLC dated October 8, 2003

  2.2   Amendment No. 1 dated November 26, 2003 to the Asset Purchase Agreement between OrthoLogic Corp. and dj Orthopedics, LLC dated October 8, 2003

  **OrthoLogic Corp. agrees to furnish supplementally a copy of any schedule to the Asset Purchase Agreement dated October 8, 2003 and to the Amendment No. 1 omitted from this filing to the Securities and Exchange Commission upon its request.

 


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
Dated: December 11, 2003   OrthoLogic Corp.
     
    /s/ Thomas Trotter
   
    Thomas Trotter
    Chief Executive Officer

 


Table of Contents

EXHIBIT INDEX

     
Exhibit    
Number   Description

 
2.1   Asset Purchase Agreement between OrthoLogic Corp. and dj Orthopedics, LLC dated October 8, 2003
     
2.2   Amendment No. 1 dated November 26, 2003 to the Asset Purchase Agreement between OrthoLogic Corp. and dj Orthopedics, LLC dated October 8, 2003
     
**   OrthoLogic Corp. agrees to furnish supplementally a copy of any schedule to the Asset Purchase Agreement dated October 8, 2003 and to the Amendment No. 1 omitted from this filing to the Securities and Exchange Commission upon its request.